This compound is a pharmaceutical intermediate featuring a complex heterocyclic structure with trifluoromethyl and trifluorophenyl substituents. It is primarily used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(Z)-3-(Hydroxyimino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
pharmaceutical intermediate
(2S,3R)-3-acetamido-2-hydroxy-4-phenylbutanoic acid
pharmaceutical intermediate
2-methyl-1,3-cyclopentanedione
pharmaceutical intermediate
Methyl 3,3-diphenyloxirane-2-carboxylate
pharmaceutical intermediate
Tert-butyl Piperazine-1-carboxylate Hydrochloride
pharmaceutical intermediate
The international HS code for 1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-1,3-butanedione (CAS 764667-65-4) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butane-1,3-dione
QAEDTLFWHIEVPK-UHFFFAOYSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(=O)CC3=CC(=C(C=C3F)F)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.